FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1979402332> ?p ?o ?g. }

• W1979402332 endingPage "55" @default.
• W1979402332 startingPage "47" @default.
• W1979402332 abstract "Current type 2 diabetes mellitus (T2DM) treatment involves progressive interventions from lifestyle changes to pharmacological therapies. Previous studies found that combination therapy with a dipeptidyl peptidase-4 inhibitor (DPP-4i) and pioglitazone (PIO) is more effective than monotherapies in treating poorly controlled T2DM, but there is no consensus on whether these drugs should be initiated at the same time (initial combination therapy) or sequentially. We aimed to assess glycemic control with initial versus sequential combination therapy with PIO and a DPP-4i in patients with glycosylated hemoglobin (HbA1c) levels ≥ 7%. A retrospective chart review was conducted on T2DM patients from diverse geographic sites in the United States initiating therapies from March 2, 2010 to February 28, 2011. Patients were selected for initial combination therapy, if starting PIO and a DPP-4i within 30 days of each other, or sequential combination therapy, if first taking PIO alone for ≥ 60 days before adding a DPP-4i within 1 year of PIO initiation. The HbA1c level reduction from baseline was compared between cohorts using linear regression models adjusting for demographics, baseline HbA1c, T2DM duration, comorbidities, and various medications. There were 250 patients in the initial and 211 in the sequential combination therapy cohorts; 57.3% were male, 65.3% were Caucasian, and the mean age was 54.3 years. Patients receiving initial combination therapy had a significantly higher mean baseline HbA1c level (8.6% vs 8.0%, P < 0.0001), a higher prevalence of coronary artery disease (11.6% vs 6.2%, P = 0.0430), and a lower prevalence of hyperlipidemia (56.4% vs 67.8%, P = 0.0120) and of hypertension (62.4% vs 72.0%, P = 0.0290), compared with the sequential therapy cohort. In adjusted analyses, initial combination therapy was associated with a significantly greater reduction in HbA1c levels than sequential combination therapy at months 12, 16, and 20 (−0.977 vs −0.819, P = 0.034; −1.453 vs −1.242, P = 0.048; and −1.182 vs −0.810, P = 0.013, respectively). Our findings suggest initial combination therapy may be the preferred option in choosing combination therapies." @default.
• W1979402332 created "2016-06-24" @default.
• W1979402332 creator A5001928872 @default.
• W1979402332 creator A5009613880 @default.
• W1979402332 creator A5022797289 @default.
• W1979402332 creator A5036390483 @default.
• W1979402332 creator A5066594351 @default.
• W1979402332 creator A5089194015 @default.
• W1979402332 date "2014-05-01" @default.
• W1979402332 modified "2023-10-16" @default.
• W1979402332 title "Management of Patients Using Combination Therapy With Pioglitazone and a Dipeptidyl Peptidase-4 Inhibitor: An Analysis of Initial Versus Sequential Combination Therapy" @default.
• W1979402332 cites W1566255677 @default.
• W1979402332 cites W1762835157 @default.
• W1979402332 cites W186896722 @default.
• W1979402332 cites W1945276862 @default.
• W1979402332 cites W1971244215 @default.
• W1979402332 cites W1983216490 @default.
• W1979402332 cites W1984588810 @default.
• W1979402332 cites W2000181789 @default.
• W1979402332 cites W2019053050 @default.
• W1979402332 cites W2025447674 @default.
• W1979402332 cites W2027249582 @default.
• W1979402332 cites W2046381181 @default.
• W1979402332 cites W2046766433 @default.
• W1979402332 cites W2047588523 @default.
• W1979402332 cites W2050938327 @default.
• W1979402332 cites W2060537172 @default.
• W1979402332 cites W2075178342 @default.
• W1979402332 cites W2086842286 @default.
• W1979402332 cites W2091775887 @default.
• W1979402332 cites W2096733280 @default.
• W1979402332 cites W2097332283 @default.
• W1979402332 cites W2098674879 @default.
• W1979402332 cites W2099621347 @default.
• W1979402332 cites W2107222124 @default.
• W1979402332 cites W2107992917 @default.
• W1979402332 cites W2108646121 @default.
• W1979402332 cites W2114041992 @default.
• W1979402332 cites W2123946565 @default.
• W1979402332 cites W2128247211 @default.
• W1979402332 cites W2128648250 @default.
• W1979402332 cites W2131063271 @default.
• W1979402332 cites W2137837290 @default.
• W1979402332 cites W2141001773 @default.
• W1979402332 cites W2146901298 @default.
• W1979402332 cites W2159969745 @default.
• W1979402332 cites W2554729258 @default.
• W1979402332 cites W2616009730 @default.
• W1979402332 cites W4229629337 @default.
• W1979402332 doi "https://doi.org/10.3810/pgm.2014.05.2755" @default.
• W1979402332 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24918791" @default.
• W1979402332 hasPublicationYear "2014" @default.
• W1979402332 type Work @default.
• W1979402332 sameAs 1979402332 @default.
• W1979402332 citedByCount "0" @default.
• W1979402332 crossrefType "journal-article" @default.
• W1979402332 hasAuthorship W1979402332A5001928872 @default.
• W1979402332 hasAuthorship W1979402332A5009613880 @default.
• W1979402332 hasAuthorship W1979402332A5022797289 @default.
• W1979402332 hasAuthorship W1979402332A5036390483 @default.
• W1979402332 hasAuthorship W1979402332A5066594351 @default.
• W1979402332 hasAuthorship W1979402332A5089194015 @default.
• W1979402332 hasConcept C126322002 @default.
• W1979402332 hasConcept C134018914 @default.
• W1979402332 hasConcept C2776999253 @default.
• W1979402332 hasConcept C2777180221 @default.
• W1979402332 hasConcept C2778213512 @default.
• W1979402332 hasConcept C2778384471 @default.
• W1979402332 hasConcept C2778763485 @default.
• W1979402332 hasConcept C2779306644 @default.
• W1979402332 hasConcept C2780473172 @default.
• W1979402332 hasConcept C2910068830 @default.
• W1979402332 hasConcept C555293320 @default.
• W1979402332 hasConcept C71924100 @default.
• W1979402332 hasConceptScore W1979402332C126322002 @default.
• W1979402332 hasConceptScore W1979402332C134018914 @default.
• W1979402332 hasConceptScore W1979402332C2776999253 @default.
• W1979402332 hasConceptScore W1979402332C2777180221 @default.
• W1979402332 hasConceptScore W1979402332C2778213512 @default.
• W1979402332 hasConceptScore W1979402332C2778384471 @default.
• W1979402332 hasConceptScore W1979402332C2778763485 @default.
• W1979402332 hasConceptScore W1979402332C2779306644 @default.
• W1979402332 hasConceptScore W1979402332C2780473172 @default.
• W1979402332 hasConceptScore W1979402332C2910068830 @default.
• W1979402332 hasConceptScore W1979402332C555293320 @default.
• W1979402332 hasConceptScore W1979402332C71924100 @default.
• W1979402332 hasIssue "3" @default.
• W1979402332 hasLocation W19794023321 @default.
• W1979402332 hasLocation W19794023322 @default.
• W1979402332 hasOpenAccess W1979402332 @default.
• W1979402332 hasPrimaryLocation W19794023321 @default.
• W1979402332 hasRelatedWork W1967473298 @default.
• W1979402332 hasRelatedWork W1998369233 @default.
• W1979402332 hasRelatedWork W2010978798 @default.
• W1979402332 hasRelatedWork W2022773701 @default.
• W1979402332 hasRelatedWork W2067917373 @default.
• W1979402332 hasRelatedWork W2172089659 @default.
• W1979402332 hasRelatedWork W2401185981 @default.

• next